Augmenting randomized clinical trial data with historical control data: Precision medicine applications. (26th September 2022)

• Record Type: Journal Article
• Authors: Freidlin, Boris; Korn, Edward L
• Is Part Of: Journal of the National Cancer Institute. Volume 115:Number 1(2023)
• Page Start: 14
• Page End: 20
• Publication Date: 2022-09-26
• Subjects: Cancer -- Periodicals; Cancer -- Research -- Periodicals; 616.994
• DOI: 10.1093/jnci/djac185
• Languages: English
• ISSNs: 0027-8874

Abstract

Abstract: As precision medicine becomes more precise, the sizes of the molecularly targeted subpopulations become increasingly smaller. This can make it challenging to conduct randomized clinical trials of the targeted therapies in a timely manner. To help with this problem of a small patient subpopulation, a study design that is frequently proposed is to conduct a small randomized clinical trial (RCT) with the intent of augmenting the RCT control arm data with historical data from a set of patients who have received the control treatment outside the RCT (historical control data). In particular, strategies have been developed that compare the treatment outcomes across the cohorts of patients treated with the standard (control) treatment to guide the use of the historical data in the analysis; this can lessen the potential well-known biases of using historical controls without any randomization. Using some simple examples and completed studies, we demonstrate in this commentary that these strategies are unlikely to be useful in precision medicine applications.